BioSpace News Archive

Deals

Omni Health Inc Possible Reverse Merger With LX Retail Group, LLC

UndergroundStocks.com, an elite wall street independent small cap media group with a history of bringing lucrative opportunities, Reports on Omni Health, Inc.

May 1, 2019
·
4 min read
Deals

Invitation to the presentation of Recipharm’s interim report January - March 2019

Recipharm AB will publish its interim report for January-March 2019 on 3 May at 07:45 am CET.

May 1, 2019
·
1 min read
Business

Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener

Codexis’ breakthrough enzyme cascade system enables better-tasting stevia product launch

May 1, 2019
·
4 min read
Deals

Auris Medical Announces Reverse Stock Split

Auris Medical Holding Ltd. announced that its Board of Directors has approved a reverse stock split of its common shares at a ratio of 1-for-20.

May 1, 2019
·
6 min read
Drug Development

Clinical Trial Results from MyoKardia’s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine

Clinical Trial Results from MyoKardia’s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine

May 1, 2019
·
11 min read
Policy

Charles River Labs Hit by Hackers, Some Client Data Compromised

The company disclosed the data breach in a filing with the U.S. Securities and Exchange Commission on Tuesday. The hacking occurred in March and the company said the data of about 1 percent of its total number of clients was compromised.

May 1, 2019
·
2 min read
·
Alex Keown
Pharm Country

BioSpace’s Global Biopharma Roundup: May 2

Pharma, biotech and life science companies from across the globe share data and progress on pipelines and other company events.

May 1, 2019
·
4 min read
·
Alex Keown
Pharm Country

Adult Congenital Heart Association Announces Funding of Organization’s Inaugural Research Grants

The six projects focus on important topics surrounding adult congenital heart disease.

May 1, 2019
·
3 min read
Deals

GENFIT: Reports First quarter 2019 Financial Information

Following the capital increase and listing on Nasdaq, cash and cash equivalents totaled €314.1 million as of March 31, 2019

May 1, 2019
·
3 min read
Deals

Biom’up reports 2018 full-year results and confirms strong commercial uptake in 1st quarter of 2019

Biom’up announced its full-year results for the year ending December 31, 2018, as approved by the Company’s Board of Directors on April 29, 2019, and provided an update on its operations.

May 1, 2019
·
17 min read